Evidence map›Paper›PMID 25392241›Full record

ArticleDiabetes2015

Connective tissue growth factor modulates adult β-cell maturity and proliferation to promote β-cell regeneration in mice.

Kimberly G Riley, Raymond C Pasek, Matthew F Maulis, Jennifer Peek, Fabrizio Thorel, David R Brigstock, Pedro L Herrera, Maureen Gannon

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Evaluation of the Effects of CCN4 on Pancreatic Beta Cell Proliferation.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Kimberly G RileyDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN.
Raymond C PasekDepartment of Medicine, Vanderbilt University, Nashville, TN.
Matthew F MaulisDepartment of Medicine, Vanderbilt University, Nashville, TN.
Jennifer PeekThe School for Science and Math at Vanderbilt, Vanderbilt University, Nashville, TN.
Fabrizio ThorelDepartment of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
David R BrigstockCenter for Cell and Vascular Biology, Children's Research Institute, The Ohio State University, Columbus, OH.
Pedro L HerreraDepartment of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
Maureen GannonDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN Department of Medicine, Vanderbilt University, Nashville, TN Department of Veterans Affairs, Tennessee Valley Health Authority, Nashville, TN Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN maureen.gannon@vanderbilt.edu.
Vanderbilt University · USUniversity of Geneva · CHTennessee Valley Authority · USThe Ohio State University · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
VANTAGE:Consolidation to create the Vanderbilt Technologies for Advanced GenomicsG20RR030956 · NCRR · VANDERBILT UNIVERSITY · PI PIETENPOL, JENNIFER A · 2010 to 2010
$8.7M
School for Science and Math at VanderbiltR25RR024261 · NCRR · VANDERBILT UNIVERSITY · PI SHEPHERD, VIRGINIA L · 2007 to 2009
$876k
Regulation of adult pancreatic beta cell replicationI01BX000990 · VA · VETERANS HEALTH ADMINISTRATION · PI GANNON, MAUREEN A · 2011 to 2014
–
MECHANISM OF CELL KILLING DURING HYPERTHERMIAR29CA058648 · NCI · WASHINGTON UNIVERSITY · PI MACKEY, MICHAEL A · 1993 to 1997
–
BLRD VA I01 BX000990NCI NIH HHS P30-CA-58648NCRR NIH HHS G20 RR030956NCRR NIH HHS G20-RR-030956NCRR NIH HHS R25 RR024261NCRR NIH HHS R25-RR-024261NEI NIH HHS P30 EY008126NEI NIH HHS P30-EY-08126NIDDK NIH HHS DK-20593NIDDK NIH HHS P30 DK020593NIDDK NIH HHS T32 DK007563NIDDK NIH HHS T32-DK-07563
6 · The paper itself

Abstract

Stimulation of endogenous β-cell expansion could facilitate regeneration in patients with diabetes. In mice, connective tissue growth factor (CTGF) is expressed in embryonic β-cells and in adult β-cells during periods of expansion. We discovered that in embryos CTGF is necessary for β-cell proliferation, and increased CTGF in β-cells promotes proliferation of immature (MafA(-)) insulin-positive cells. CTGF overexpression, under nonstimulatory conditions, does not increase adult β-cell proliferation. In this study, we tested the ability of CTGF to promote β-cell proliferation and regeneration after partial β-cell destruction. β-Cell mass reaches 50% recovery after 4 weeks of CTGF treatment, primarily via increased β-cell proliferation, which is enhanced as early as 2 days of treatment. CTGF treatment increases the number of immature β-cells but promotes proliferation of both mature and immature β-cells. A shortened β-cell replication refractory period is also observed. CTGF treatment upregulates positive cell-cycle regulators and factors involved in β-cell proliferation, including hepatocyte growth factor, serotonin synthesis, and integrin β1. Ex vivo treatment of whole islets with recombinant human CTGF induces β-cell replication and gene expression changes consistent with those observed in vivo, demonstrating that CTGF acts directly on islets to promote β-cell replication. Thus, CTGF can induce replication of adult mouse β-cells given a permissive microenvironment.

Indexed as

AnimalsCadherinsCell CycleCell DeathCell ProliferationConnective Tissue Growth FactorHepatocyte Growth FactorInsulin-Secreting CellsIntegrin beta1MiceRegenerationCadherinsConnective Tissue Growth FactorHepatocyte Growth FactorIntegrin beta1

Identifiers

PMID25392241
PMCPMC4375083
OpenAlexW2149858472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.